SRNE - Sorrento Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
No. of Analysts1121
Avg. Estimate-0.22-0.16-0.76-0.56
Low Estimate-0.22-0.16-0.86-0.56
High Estimate-0.22-0.16-0.66-0.56
Year Ago EPS-0.46-0.5-2.2-0.76
Revenue EstimateCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
No. of Analysts1121
Avg. Estimate8M11.53M29.13M106.72M
Low Estimate8M11.53M15.9M106.72M
High Estimate8M11.53M42.36M106.72M
Year Ago Sales7.75M5.78M31.43M29.13M
Sales Growth (year/est)3.20%99.60%-7.30%266.40%
Earnings History6/29/20199/29/201912/30/20193/30/2020
EPS Est.-0.4-0.43-0.38-0.2
EPS Actual-0.46-0.5-0.41-0.36
Difference-0.06-0.07-0.03-0.16
Surprise %-15.00%-16.30%-7.90%-80.00%
EPS TrendCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
Current Estimate-0.22-0.16-0.76-0.56
7 Days Ago-0.23-0.22-0.83-0.93
30 Days Ago-0.23-0.22-0.83-0.93
60 Days Ago-0.23-0.25-0.8-0.84
90 Days Ago-0.23-0.25-0.8-0.84
EPS RevisionsCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
Up Last 7 Days1111
Up Last 30 Days1111
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesSRNEIndustrySector(s)S&P 500
Current Qtr.52.20%N/AN/AN/A
Next Qtr.68.00%N/AN/AN/A
Current Year65.50%N/AN/AN/A
Next Year26.30%N/AN/AN/A
Next 5 Years (per annum)37.00%N/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A